Financials
- Market Capitalization 8.1 B
- Employee 691
- Founded 2014
- CEO Rich Adcock
- Website www.immunitybio.com
- Headquarter Delaware, United States
- FIGI BBG007T9DYW9
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-9.02
Fiyat/satışlar oranı
51.72
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 1030 | PCVX Vaxcyte, Inc. - Common Stock | 56.73 USD | +0.93% | -3.37% | +14.44% | +34.11% | 8.19 B USD | ||
| 1032 | IMVT Immunovant, Inc. - Common Stock | 39.89 USD | +2.89% | -1.04% | +20.11% | +107.65% | 8.19 B USD | ||
| 1057 | KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 61.69 USD | -0.47% | -4.74% | +18.18% | +55.61% | 7.71 B USD | ||
| 1077 | RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 109.62 USD | -0.31% | -4.09% | +20.54% | -0.63% | 7.51 B USD |